SENS-AI
Debt Notice Neutral

GOLDMAN SACHS INTERNATIONAL - New listing notification GS178C

Full analysis

What this filing means

Goldman Sachs International has listed a new ZAR 100 million structured note (GS178C) linked to Prosus NV shares on the JSE.

Goldman Sachs has created and listed a new financial product on the stock exchange. The value of this product is tied to the performance of Prosus shares, giving investors another way to gain exposure to that company.

Bull case

  • The JSE has granted a listing for the GS178C structured product, expanding the range of available instruments under the Series P Programme.
  • The issuance of ZAR 100 million in notes provides additional investment options for market participants seeking exposure to Prosus NV.

Bear case

  • The instrument introduces counterparty risk as it relies on the creditworthiness of Goldman Sachs International and Goldman Sachs Group, Inc.
  • The product's performance is tied to Prosus NV shares, exposing investors to underlying equity volatility.
  • The long-dated maturity in April 2029 creates duration risk and potential tracking variance over the holding period.
View original SENS announcement

AI-generated summary by SENS-AI, based on the original JSE SENS filing.

SENS-AI conclusion

This announcement details the listing of a ZAR 100 million structured note (GS178C) by Goldman Sachs International, linked to the performance of Prosus NV. The issuance represents routine product structuring and expands the availability of derivative instruments on the JSE. This does not impact the equity capitalization or fundamental investment thesis of Prosus NV itself. Investor Takeaway: This is a mechanical debt and structured product listing with no direct equity implications for the underlying reference asset. Rating Context: This is a scheduled debt servicing event with no direct equity impact.

Routine filing. No equity signal. No portfolio action required.

Decision framework

Current stance: Filing Neutral

Key drivers

  • The JSE has granted a listing for the GS178C structured product, expanding the range of available instruments under the Series P Programme.
  • The issuance of ZAR 100 million in notes provides additional investment options for market participants seeking exposure to Prosus NV.

Key risks

  • The instrument introduces counterparty risk as it relies on the creditworthiness of Goldman Sachs International and Goldman Sachs Group, Inc.
  • The product's performance is tied to Prosus NV shares, exposing investors to underlying equity volatility.
  • The long-dated maturity in April 2029 creates duration risk and potential tracking variance over the holding period.

What would change the view

  • Guidance and cash-flow quality both improve materially from current baseline.
  • Subsequent filings remove current uncertainty and confirm durable execution.
  • Market structure/positioning shifts enough to support a directional thesis.

Evidence from the filing

  • The JSE has granted a listing for the GS178C structured product, expanding the range of available instruments under the Series P Programme.

    “The JSE Limited has granted a listing to Goldman Sachs International under the Series P Programme for the issuance of Warrants, Notes and Certificates on the Main Board with effect from 16 April 2026.”

  • The issuance of ZAR 100 million in notes provides additional liquidity and investment options for market participants seeking exposure to Prosus NV.

    “Nominal Amount ZAR100,000,000.00.”

  • The instrument introduces counterparty risk as it is issued by Goldman Sachs International and guaranteed by Goldman Sachs Group, Inc., creating a dependency on the creditworthiness of the issuer and guarantor over the three-year term.

    “GOLDMAN SACHS INTERNATIONAL (incorporated with unlimited liability in in England and Wales on 2 June 1988) (Structured Product Issuer Code: GDIP) (the Issuer) GOLDMAN SACHS GROUP, INC (incorporated in the State of Delaware on 21 July 1998) (as Guarantor)”

  • The product's performance is directly linked to the ordinary shares of Prosus NV, exposing investors to the underlying equity volatility and potential liquidity constraints inherent in the structured product's specific payout structure.

    “The ordinary shares of Prosus NV (Bloomberg page: PRX NA Equity; Reuters screen: PRX.AS; ISIN: NL0013654783)”

  • The long-dated nature of the instrument, with a final maturity date in April 2029, creates significant duration risk and potential for tracking error relative to the underlying Prosus NV equity performance over the multi-year holding period.

    “Final Maturity / Settlement Date Tuesday, 17 April 2029”
Category
Debt Notice
Published
Apr 15, 2026

Related filings